ATE307827T1 - Respiratorisches syncytialvirus; impfstoffe und diagnostische tests - Google Patents

Respiratorisches syncytialvirus; impfstoffe und diagnostische tests

Info

Publication number
ATE307827T1
ATE307827T1 AT97114674T AT97114674T ATE307827T1 AT E307827 T1 ATE307827 T1 AT E307827T1 AT 97114674 T AT97114674 T AT 97114674T AT 97114674 T AT97114674 T AT 97114674T AT E307827 T1 ATE307827 T1 AT E307827T1
Authority
AT
Austria
Prior art keywords
respiratory syncytial
syncytial virus
vaccines
diagnostic tests
polypeptides
Prior art date
Application number
AT97114674T
Other languages
English (en)
Inventor
Peter Paradiso
Stephen W Hildreth
Branda T Hu
Antonia Martin-Gallardo
Rasappa Arumugham
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26799096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE307827(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE307827T1 publication Critical patent/ATE307827T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97114674T 1987-09-29 1988-09-29 Respiratorisches syncytialvirus; impfstoffe und diagnostische tests ATE307827T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10218087A 1987-09-29 1987-09-29
US07/247,017 US5223254A (en) 1987-09-29 1988-09-20 Respiratory syncytial virus: vaccines

Publications (1)

Publication Number Publication Date
ATE307827T1 true ATE307827T1 (de) 2005-11-15

Family

ID=26799096

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88909698T ATE163682T1 (de) 1987-09-29 1988-09-29 Respiratorisches syncytiales virus, impstoffe
AT97114674T ATE307827T1 (de) 1987-09-29 1988-09-29 Respiratorisches syncytialvirus; impfstoffe und diagnostische tests

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT88909698T ATE163682T1 (de) 1987-09-29 1988-09-29 Respiratorisches syncytiales virus, impstoffe

Country Status (10)

Country Link
US (1) US5223254A (de)
EP (2) EP0814089B1 (de)
JP (1) JP3288692B2 (de)
KR (1) KR960013578B1 (de)
AT (2) ATE163682T1 (de)
AU (1) AU636838B2 (de)
BR (1) BR1101088A (de)
DE (2) DE3856586T2 (de)
DK (1) DK175500B1 (de)
WO (1) WO1989002935A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
JP2716503B2 (ja) * 1987-12-23 1998-02-18 ジ・アップジョン・カンパニー ヒト呼吸系シンシチウムウイルスの糖蛋白類の免疫原性セグメントを含有するキメラ糖蛋白類
JPH05509231A (ja) * 1990-07-24 1993-12-22 ザ ユーエイビー リサーチ ファンデーション ウシｒｓウイルスの組換えｄｎａ、タンパク質ワクチン、抗体、および形質転換細胞の使用法
US6730305B1 (en) 2000-05-08 2004-05-04 The Uab Research Foundation Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
DK0545951T3 (da) * 1990-08-31 1994-10-17 Upjohn Co HRSV-vaccine
US5824307A (en) 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
TW275632B (de) * 1992-04-21 1996-05-11 American Cyanamid Co
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US6017536A (en) * 1993-06-07 2000-01-25 Trimeris, Inc. Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6518013B1 (en) 1993-06-07 2003-02-11 Trimeris, Inc. Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission
EP0724602A4 (de) * 1993-07-30 1998-12-23 Oravax Inc MONOKLONALE IgA-ANTIKÖRPER GEGEN DAS RESPIRATORISCHE SYNZYTIALVIRUS
US7223410B1 (en) 1994-08-05 2007-05-29 Sanofi Pasteur Limited Inactivated respiratory syncytial viral vaccines
DE69409243T2 (de) * 1993-08-06 1998-08-06 Connaught Lab Inaktivierte respiratorische synzytial-virus-impfstoffe
WO1996010400A1 (en) * 1994-09-30 1996-04-11 The Uab Research Foundation Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
US5716821A (en) * 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
ES2257744T3 (es) * 1994-10-05 2006-08-01 Vanderbilt University Interleuquina-12 como adyuvante para vacunas contra paramyxoviridae.
FR2726576B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Production de peptides analogues de peptides hydrophobes, peptide recombinant, sequence d'adn correspondante
FR2726577B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
SE9600646D0 (sv) * 1996-02-21 1996-02-21 Bror Morein Vaccin
AU2438597A (en) * 1996-04-04 1997-10-29 Regents Of The University Of Michigan, The Attenuated respiratory syncytial virus
US6077514A (en) * 1996-04-04 2000-06-20 The Regents Of The University Of Michigan Attenuated respiratory syncytial virus
US6180398B1 (en) * 1996-07-12 2001-01-30 Virogeneitics Corporation Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
FR2766192B1 (fr) * 1997-07-17 2001-07-13 Pf Medicament Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
TR200103266T2 (tr) * 1999-05-13 2002-01-21 American Cyanamid Company Yardımcı kombinasyon formülasyonları
ES2349348T3 (es) * 2000-01-27 2010-12-30 Medimmune, Llc Anticuerpos neutralizantes de rsv de ultra alta afinidad.
CA2401652A1 (en) * 2000-03-01 2001-09-07 Medimmune, Inc. High potency recombinant antibodies and method for producing them
US7117033B2 (en) * 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
AU5662001A (en) 2000-05-08 2001-11-20 Brainsgate Ltd. Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow
US7146209B2 (en) * 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
EE200300172A (et) * 2000-11-10 2003-06-16 Wyeth Holdings Corporation Antigeenne kompositsioon ja adjuvantsegu
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
FR2827605B1 (fr) * 2001-07-20 2004-07-16 Pf Medicament Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
IL164828A0 (en) * 2002-04-25 2005-12-18 Brainsgate Ltd Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
US7684859B2 (en) * 2002-04-25 2010-03-23 Brainsgate Ltd. Stimulation of the OTIC ganglion for treating medical conditions
US7636597B2 (en) * 2002-11-14 2009-12-22 Brainsgate, Ltd. Surgical tools and techniques for stimulation
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
US7561919B2 (en) * 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8010189B2 (en) * 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US20090299418A1 (en) * 2004-08-23 2009-12-03 Brainsgate Ltd. Concurrent bilateral spg modulation
WO2006034292A2 (en) * 2004-09-21 2006-03-30 Medimmune, Inc. Antibodies against and methods for producing vaccines for respiratory syncytial virus
CA2585891A1 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
US7875426B2 (en) * 2005-02-04 2011-01-25 University Of South Florida DNA biochip and methods of use
US20090210026A1 (en) * 2006-08-17 2009-08-20 Brainsgate Ltd. Spg stimulation for enhancing neurogenesis and brain metabolism
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
US7860569B2 (en) 2007-10-18 2010-12-28 Brainsgate, Ltd. Long-term SPG stimulation therapy for prevention of vascular dementia
US8852608B2 (en) 2009-02-02 2014-10-07 Medimmune, Llc Antibodies against and methods for producing vaccines for respiratory syncytial virus
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
CN102294027A (zh) * 2011-07-26 2011-12-28 昆明理工大学 一种呼吸道合胞病毒f2蛋白亚单位疫苗及其制备方法
ES2395677B1 (es) * 2011-07-29 2013-12-26 Instituto De Salud Carlos Iii Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
EP3656396A1 (de) 2012-08-01 2020-05-27 Bavarian Nordic A/S Rekombinanter modifizierter impfstoffvirus ankara (mva) gegen das respiratorische synzytialvirus (rsv)
EP2878335B1 (de) 2013-11-10 2018-01-03 Brainsgate Ltd. Implantat und implantationssystem für nervenstimulator
EP3093043B1 (de) 2015-05-13 2018-11-14 Brainsgate Ltd. Implantat und abgabesystem für nervenstimulator
WO2024084785A1 (ja) * 2022-10-20 2024-04-25 一般財団法人阪大微生物病研究会 Ｒｓウイルスワクチンとしての利用に好適な組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501357A (ja) * 1986-01-14 1989-05-18 ユニバ−シテイ・オブ・ノ−ス・カロライナ ヒト呼吸器系ウイルス用ワクチン
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines

Also Published As

Publication number Publication date
AU2613388A (en) 1989-04-18
JP3288692B2 (ja) 2002-06-04
WO1989002935A1 (en) 1989-04-06
BR1101088A (pt) 2002-04-02
ATE163682T1 (de) 1998-03-15
EP0390799A1 (de) 1990-10-10
EP0814089B1 (de) 2005-10-26
EP0814089A3 (de) 2003-12-17
AU636838B2 (en) 1993-05-13
DE3856586D1 (de) 2005-12-01
DK175500B1 (da) 2004-11-15
KR890701770A (ko) 1989-12-21
EP0390799B1 (de) 1998-03-04
DE3856141T2 (de) 1998-06-25
US5223254A (en) 1993-06-29
EP0390799A4 (en) 1992-09-02
DE3856141D1 (en) 1998-04-09
DE3856586T2 (de) 2006-05-24
KR960013578B1 (ko) 1996-10-09
JPH03502687A (ja) 1991-06-20
EP0814089A2 (de) 1997-12-29
DK79190D0 (da) 1990-03-28
DK79190A (da) 1990-05-07

Similar Documents

Publication Publication Date Title
ATE307827T1 (de) Respiratorisches syncytialvirus; impfstoffe und diagnostische tests
DK0458079T3 (da) Ultralyd-kontrastmidler, fremgangsmåde til deres fremstilling og deres anvendelse som diagnostika og terapeutika
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
ATE178907T1 (de) Rezeptorbindende region des diphtherietoxius
DK186490A (da) Ultrasoniske kontrastmidler og fremgangsmaade til fremstilling deraf samt deres anvendelse
DK93388A (da) Lav-virusvarianter, dna- og proteinbestanddele deraf og anvendelse deraf, saerlig til diagnostiske formaal og til fremstilling af immunogene praeparater
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
ATE127345T1 (de) Stressproteine und verwendungen dafür.
SE8604007D0 (sv) Vaccin och immunoanalyser for forvervat immunbristsyndrom (aids)
DK163683D0 (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykkedna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
DK235687D0 (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
ATE157258T1 (de) Zubereitungen und behandlungen von pneumonia in tieren
ATE77957T1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
DE10075036I2 (de) Impfstoff und Diagnostikum f}r den Schweine-Cholera-Virus.
EP0601108A4 (en) Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects.
DK204588A (da) Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider
SE8803062L (sv) Sekvensiella polypeptider med immunologisk aktivitet
ATE143373T1 (de) Proteine, vakzine und nucleinsäuren
AU2715288A (en) Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein
IT8621144A0 (it) Polipeptide utile per lapreparazione di vaccini per la malaria e di kits diagnostici per la determinazione di affezioni malariche.
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0814089

Country of ref document: EP

REN Ceased due to non-payment of the annual fee